World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
82
Citations
19389
World Ranking
3769
National Ranking
1866

Kenneth O. Lloyd publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Kenneth O. Lloyd sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 202 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Kenneth O. Lloyd D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Kenneth O. Lloyd sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 82 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Kenneth O. Lloyd is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to subfields such as Neurology, Oncology, Immunology, Immunology and Allergy, and Radiology, Nuclear Medicine and Imaging.

The scientist's research topics notably include:

  • Neuroblastoma Research and Treatments
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Cell Adhesion Molecules Research
  • Monoclonal and Polyclonal Antibodies Research
  • Biochemical and Structural Characterization
  • Microtubule and mitosis dynamics

Lloyd's recent papers illustrate active involvement in oncology and immunology-related studies. The recent publications are:

  • CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness, 2024, Science Advances
  • Synthetic integrin antibodies discovered by yeast display reveal αV subunit pairing preferences with β subunits, 2024, mAbs
  • Synthetic integrin antibodies discovered by yeast display reveal αV subunit pairing preferences with β subunits, 2024, bioRxiv (Cold Spring Harbor Laboratory)
  • Abstract 5498: Plinabulin, a novel tubulin targeting agent, collapses the proinvasion tumor microtube network in primary and recurrent patient derived glioblastoma cell lines to inhibit neurosphere invasion and survival, 2022, Cancer Research
  • Tregcells drive MYCN-mediated immunosuppression and tumor aggressiveness in high-risk neuroblastoma, 2022, bioRxiv (Cold Spring Harbor Laboratory)

Collaborative efforts are evident through frequent co-authors including:

  • Rob Meijers
  • Xiaodan Qin
  • Andrew Lam
  • Satyaki Sengupta
  • Tao Zuo

The scientist has published consistently in several venues, with the most frequent being:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Science Advances
  • mAbs
  • Molecular Cancer Therapeutics

Their work touches on topics that relate to tumor biology, immune suppression mechanisms, antibody discovery, and therapeutic strategies involving microtubule dynamics and cell adhesion. Specific areas such as MYCN-mediated tumor aggressiveness and immune cell interactions are recurrent themes in their recent output.

Best Publications

  • Molecular Cloning of the CA125 Ovarian Cancer Antigen: IDENTIFICATION AS A NEW MUCIN, MUC16

    Beatrice W.T. Yin;Kenneth O. Lloyd

  • The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

    Rogier W. Sanders;Miro Venturi;Linnea Schiffner;Roopa Kalyanaraman

  • Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies

    Wolfgang G. Dippold;Kenneth O. Lloyd;Lucy T. C. Li;Hisami Ikeda

  • GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.

    Clifford S. Pukel;Kenneth O. Lloyd;Luiz R. Travassos;Wolfgang G. Dippold

  • Comparison of O-Linked Carbohydrate Chains in MUC-1 Mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma Cell Lines: DEMONSTRATION OF SIMPLER AND FEWER GLYCAN CHAINS IN TUMOR CELLS

    Kenneth O. Lloyd;Joy Burchell;Valery Kudryashov;Beatrice W.T. Yin

  • Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides

    Shengle Zhang;Carlos Cordon-Cardo;Helen S. Zhang;Victor E. Reuter

  • Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens

    Shengle Zhang;Helen S. Zhang;Carlos Cordon-Cardo;Victor E. Reuter

  • Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies

    Yves Fradet;Carlos Cordon-Cardo;Timothy Thomson;Mary E. Daly

  • Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man

    S. F. Slovin;G. Ragupathi;S. Adluri;G. Ungers

  • Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines.

    Junichi Sakamoto;Koichi Furukawa;Carlos Cordon-Cardo;Beatrice W. T. Yin

  • Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody

    M Haraguchi;S Yamashiro;A Yamamoto;K Furukawa

  • Expression of Lewisa, Lewisb, Lewisx, Lewisy, Sialyl-Lewisa, and Sialyl-Lewisx Blood Group Antigens in Human Gastric Carcinoma and in Normal Gastric Tissue

    Junichi Sakamoto;Tadashi Watanabe;Takahiko Tokumaru;Hiroshi Takagi

  • Immunochemical studies on blood groups. XLI. Proposed structures for the carbohydrate portions of blood group A, B, H, Lewis-a, and Lewis-b substances.

    Kenneth O. Lloyd;Elvin A. Kabat

  • Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens.

    A P Albino;K O Lloyd;A N Houghton;H F Oettgen

  • Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides.

    Y Nagata;S Yamashiro;J Yodoi;K O Lloyd

  • Immunochemical Studies on Blood Groups. XXXIV. Structures of Some Oligosaccharides Produced by Alkaline Degradation of Blood Group A, B, and H Substances*

    Kenneth O. Lloyd;Elvin A. Kabat;Espriela J. Layug;Flavio Gruezo

  • Philip Levine award lecture. Blood group antigens as markers for normal differentiation and malignant change in human tissues.

    Kenneth O. Lloyd

  • Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.

    Wm. Bradley Hamilton;Friedhelm Helling;Kenneth O. Lloyd;Philip O. Livingston

  • Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins

    Ryuzo Ueda;Shun-Ichiro Ogata;Donna M. Morrissey;Connie L. Finstad

  • Isolation, characterization, and partial structure of peptido galactomannans from the yeast form of Cladosporium werneckii.

    Kenneth O. Lloyd

Frequent Co-Authors

Lloyd J. Old
Lloyd J. Old Ludwig Cancer Research
Herbert F. Oettgen
Herbert F. Oettgen Memorial Sloan Kettering Cancer Center
Philip O. Livingston
Philip O. Livingston Memorial Sloan Kettering Cancer Center
Stephen C. Rubin
Stephen C. Rubin University of Pennsylvania
William J. Hoskins
William J. Hoskins Memorial Sloan Kettering Cancer Center
Carlos Cordon-Cardo
Carlos Cordon-Cardo Icahn School of Medicine at Mount Sinai
Koichi Furukawa
Koichi Furukawa Chubu University
Hiroshi Shiku
Hiroshi Shiku Mie University
Francisco X. Real
Francisco X. Real Pompeu Fabra University
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Kenneth O. Lloyd

Trending Scientists

Recently Published Articles